Navigation Links
InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
Date:9/16/2009

Optiferrin shown to provide superior performance in cell culture and addresses the need for animal-free transferrin in many applications including Stem Cells, Primary Cells, Hybridoma Cells and Chinese Hamster Ovary (CHO) cells.

Fort Collins, CO (PRWEB) September 16, 2009 -- InVitria today announced the launch of Optiferrin, a high performance, well-defined and animal-free recombinant transferrin for use in mammalian cell culture. Optiferrin is a cell culture supplement which supports cell growth by regulating the amount of iron transported to the cell. Since iron is required for healthy cell culture performance, it is a critical component to reach optimal performance.

"Optiferrin has undergone extensive testing by our beta customers since June 2009. They have formulated Optiferrin into their cell culture media to provide maximum performance and they liked their results. We are delighted to be able to bring this sort of value to our customers through innovations like Optiferrin," said Scott Deeter, President & CEO of InVitria.

"Transferrin is nature's way to deliver iron in a non-toxic manner," said Dr. Steve Pettit, InVitria's Director of Cell Culture Development. "Our product development, along with beta customer results, confirmed that Optiferrin delivered optimal performance without any cell damage. This alleviates customer's concerns about animal-origin infectious contaminants or the headaches caused by addition of elemental iron and iron chelators in cell culture media," said Dr. Pettit.

Optiferrin is a complimentary product to InVitria's other cell culture supplement products, which include Cellastim, Lacromin, Zap-CHO and Zap-Hybridoma.

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's product line, contact us at info(at)InVitria(dot)com or call 1-800-916-8311.

# # #

Read the full story at http://www.prweb.com/releases/Optiferrin/recombinanttransferrin/prweb2895654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Cell Culture Product Line to Headline PEACe
2. InVitria Sponsors ESACT 2009 in Dublin, Ireland
3. InVitria to Present at BIO 2009 International Convention in Atlanta
4. InVitria Reveals Technology to Optimize Hybridoma Production Performance
5. InVitria Headlines Sponsorship of WilBio's Waterside Conference
6. InVitria Announces Launch of Recombinant Albumin for Diagnostics
7. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
8. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
9. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
10. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
11. InVitria to Present at WilBio's International Cell Engineering Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical ... begin serving as new board chair for Orange County health care system CalOptima ... remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in ... quality care can be limited while the desire to conquer breakouts and eliminate skincare ... care for every customer online, today released its inaugural survey on the State of ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... The Executives, ... to raise money to for the Toys for Tots Literacy Campaign at their Semi-Annual ... in excess of $70 billion, the U.S. ranks at number 14 internationally in literacy. ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... which will be offered by the American Association of Integrative Medicine and available ... for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Bayer and its partnering interests and ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ... and company data. The report will be delivered ...
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: ... it intends to offer shares of common stock in ... statement on file with the Securities and Exchange Commission ... other conditions, and there can be no assurance as ... or as to the actual size or terms of ...
(Date:3/27/2017)...  A new survey from the American ... Bidding Program (CBP) significantly reduced beneficiary choice and access ... choice forces beneficiaries to switch to unfamiliar or unsuitable ... AADE,s survey is the latest in a ... out the inherent problems with the CBP. Last year, ...
Breaking Medicine Technology: